QQ客服 官方微博 反馈留言

	Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling
	Li N.; Feng F.; Wu K.; Zhang H.; Zhang W.; Wang W.
刊名	Biomedicine and Pharmacotherapy
	2019
卷号	119
关键词	Astragaloside ASV Extracellular matrix Pulmonary fibrosis Silicosis Transforming growth factor-beta 1
DOI	10.1016/j.biopha.2019.109387
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4560350
专题	山东大学
作者单位	Department of Respiratory Medicine, The Second Hospital of Shandong University, Jinan, Shandong 250033, China, Department of Respiratory Medi
推荐引用方式 GB/T 7714	Li N.,Feng F.,Wu K.,et al. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling[J]. Biomedicine and Pharmacotherapy,2019,119.
APA	Li N.,Feng F.,Wu K.,Zhang H.,Zhang W.,&Wang W..(2019).Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.Biomedicine and Pharmacotherapy,119.
MLA	Li N.,et al."Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling".Biomedicine and Pharmacotherapy 119(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。